Myomo (MYO) FCF Margin Growth (1y) (2017 - 2025)
Analysis
Myomo (MYO) FCF Margin Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 194.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 984.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 641.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 66.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 119.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 1,788.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -177.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -395.00 |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -473.00 |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,769.00 |
| Jun 30, 2025 | -6,857.00 |
| Mar 31, 2025 | 5,399.00 |
| Dec 31, 2024 | 7,095.00 |
| Sep 30, 2024 | 1,511.00 |
| Jun 30, 2024 | -2,202.00 |
| Mar 31, 2024 | -3,402.00 |
| Dec 31, 2023 | 1,086.00 |
| Sep 30, 2023 | 3,585.00 |
| Jun 30, 2023 | 6,840.00 |
| Mar 31, 2023 | 732.00 |
| Dec 31, 2022 | -1,511.00 |
| Sep 30, 2022 | -1,902.00 |
| Jun 30, 2022 | 4,253.00 |
| Mar 31, 2022 | 3,099.00 |
| Dec 31, 2021 | -1,565.00 |
| Sep 30, 2021 | 4,237.00 |
| Jun 30, 2021 | 31,099.00 |
| Mar 31, 2021 | 15,098.00 |
| Dec 31, 2020 | 14,448.00 |